Earnings Alerts

Unimicron Technology (3037) Earnings: FY Net Income Falls Short of Estimates with NT$5.08 Billion

By February 25, 2025 No Comments
  • Unimicron’s full-year net income fell short of expectations, coming in at NT$5.08 billion compared to the estimated NT$6.91 billion.
  • The company’s operating profit reached NT$5.12 billion.
  • Earnings per share (EPS) were NT$3.34, below the forecast of NT$4.55.
  • Total revenue totaled NT$115.37 billion, slightly under the projected NT$116.76 billion.
  • Analyst recommendations include 19 buys, 2 holds, and 1 sell for Unimicron.

A look at Unimicron Technology Smart Scores

FactorScoreMagnitude
Value3
Dividend3
Growth3
Resilience3
Momentum3
OVERALL SMART SCORE3.0

Smart Score is a compound score for the Company indicating its overall outlook. It is derived by taking an equally weighted average of underlying Factor scores computed by Smartkarma

Unimicron Technology Corp., a company specializing in the manufacturing of double-sided and multi-layer printed circuit boards, as well as offering integrated circuits (IC) burning and testing services, has received moderate scores across the board according to Smartkarma Smart Scores. With a rating of 3 in key areas such as Value, Dividend, Growth, Resilience, and Momentum, Unimicron Technology is positioned steadily in terms of its overall outlook.

Looking ahead, Unimicron Technology seems to hold a consistent performance across various metrics, indicating a balanced stance in the market. While scoring neither too high nor too low across different factors, the company’s stability and potential for future growth appear to be well-managed. Investors may find Unimicron Technology to be a stable choice with decent prospects moving forward based on the aggregated Smart Scores in different areas.


Disclaimer: This article by Smartkarma is general in nature and based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. Note that our articles may not factor in the latest price-sensitive company announcements or qualitative material.
While all reasonable care has been taken in the preparation, Smartkarma makes no assurance about the accuracy of any generated data or content. All content is indicative only and should be independently checked for accuracy and confirmed before use. Smartkarma accepts no responsibility for any loss or damage caused as a result of any inaccuracy or error within the Lab online tools or generated data.
Have feedback on this article? Concerned about the content? Get in touch with us directly.


 

πŸ’‘ Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • βœ“ Unlimited Research Summaries
  • βœ“ Personalised Alerts
  • βœ“ Custom Watchlists
  • βœ“ Company Analytics and News
  • βœ“ Events & Webinars